DigestRedComo funciona
Red
/
Empresas
Cy
No verificado

Cycle Pharmaceuticals

Sobre qué escribimos

BiotecnologíaFarmacéuticaHigiene alimentariaIndustriaSalud

6 Comunicados de prensa

Ver todos los comunicados de prensa
16/10/2025
Biotecnología
Higiene alimentaria
Salud
Farmacéutica
Oncología
Industria
Cycle Pharmaceuticals Launches Its First Oncology Product, PHYRAGO™ (dasatinib) Tablets, in the US
Fuente
Cycle Pharmaceuticals
Editor
Business Wire
1.00
0
21/07/2025
Biotecnología
Salud
Farmacéutica
Oncología
Industria
Cycle Pharmaceuticals Signs Exclusive U.S. Sales License for PHYRAGO™ (dasatinib) Tablets
Fuente
Cycle Pharmaceuticals
Editor
Business Wire
1.00
0
17/07/2025
Ciencia
Higiene alimentaria
Biotecnología
Medicina - Varios
Salud
Farmacéutica
Sanidad
Industria
Cycle Pharmaceuticals launches HARLIKU™ (nitisinone) Tablets, the first FDA-approved treatment for use in Alkaptonuria (AKU)
Fuente
Cycle Pharmaceuticals
Editor
Business Wire
1.00
0
19/06/2025
Salud
Higiene alimentaria
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Industria
Cycle Pharmaceuticals’ HARLIKU™ (nitisinone) Tablets Receive First FDA-Approval as Treatment for Alkaptonuria (AKU)
Fuente
Cycle Pharmaceuticals
Editor
Business Wire
1.00
0
22/04/2025
Industria
Biotecnología
Higiene alimentaria
Sanidad
Salud
Farmacéutica
Ciencia
Medicina - Varios
Cycle Pharmaceuticals Launches Cycle Vita PKU™, an AI-Powered Smartphone App for On-The-Go Management of Phenylketonuria (PKU)
Fuente
Cycle Pharmaceuticals
Editor
Business Wire
1.00
0
14/10/2024
Mercado de valores
Biotecnología
Farmacéutica
Salud
Cycle Pharmaceuticals Reaffirms All-Cash Proposal to Acquire Vanda Pharmaceuticals for $8.00 Per Share
Fuente
Cycle Pharmaceuticals
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0